Your Health Plan:
LUCENTIS (ranibizumab) is a biologic prescription drug for treatment of Age related macular degeneration, Retinal Vein Occlusion, Macular edema due to diabetes mellitus, Diabetic Retinopathy and Myopic choroidal neovascularization. LUCENTIS is a vascular endothelial growth factor inhibitor. It is available in the form of intravitreal injection.
See full Prescribing Information for important safety information and clinical studies.
LUCENTIS is not covered by . Cash price for 30-day supply is $1300-2700.
Patient Assistance Prorgams and Coupons are found:
